Cited by

• Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5' untranslated region (5'UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5'UTR sequence.

  Tang S, Collier AJ, Elliott RM. Tang S, et al. J Virol. 1999 Mar;73(3):2359-64. doi: 10.1128/JVI.73.3.2359-2364.1999. J Virol. 1999. PMID: 9971819 Free PMC article.
• Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era.

  Durmuş Tekir SD, Ülgen KÖ. Durmuş Tekir SD, et al. Biotechnol J. 2013 Jan;8(1):85-96. doi: 10.1002/biot.201200110. Epub 2012 Nov 29. Biotechnol J. 2013. PMID: 23193100 Free PMC article. Review.
• A potential RNA drug target in the hepatitis C virus internal ribosomal entry site.

  Klinck R, Westhof E, Walker S, Afshar M, Collier A, Aboul-Ela F. Klinck R, et al. RNA. 2000 Oct;6(10):1423-31. doi: 10.1017/s1355838200000935. RNA. 2000. PMID: 11073218 Free PMC article.
• Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

  Alekseeva E, Sominskaya I, Skrastina D, Egorova I, Starodubova E, Kushners E, Mihailova M, Petrakova N, Bruvere R, Kozlovskaya T, Isaguliants M, Pumpens P. Alekseeva E, et al. Genet Vaccines Ther. 2009 Jun 8;7:7. doi: 10.1186/1479-0556-7-7. Genet Vaccines Ther. 2009. PMID: 19505299 Free PMC article.
• Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.

  Sominskaya I, Skrastina D, Dislers A, Vasiljev D, Mihailova M, Ose V, Dreilina D, Pumpens P. Sominskaya I, et al. Clin Vaccine Immunol. 2010 Jun;17(6):1027-33. doi: 10.1128/CVI.00468-09. Epub 2010 Apr 21. Clin Vaccine Immunol. 2010. PMID: 20410327 Free PMC article.